Categories
COVID-19 Vaccine Update India Market

Sputnik V manufacturing pact adds another feather to Gland Pharma’s cap

Sumary of Sputnik V manufacturing pact adds another feather to Gland Pharma’s cap:

  • Gland Pharma Ltd, with its prowess in injectables manufacturing, has now become part of the global supply chain for covid-19 vaccines…
  • The company entering into an agreement with the Russian Direct Investment Fund (RDIF) to supply up to 252 million doses of RDIF Sputnik V vaccine will boost Street confidence further…
  • On the pricing of the vaccine, which is below $10 (less than ₹730), analysts at Haitong Securities India Private Ltd said it brings the total opportunity size in the range of ₹800- ₹1700 crore depending on the price ( ₹350-700 per dose)…
  • However, they believe this size could shrink to ₹400 crore if the procurement cost would be at ₹150-175 per dose like in India…
  • Though the agreement is positive, analysts are also watchful on available vacant capacities for vaccine manufacturing by Gland Pharma, The agreement included drug substance manufacturing, which brings uncertainty to the commercial aspect of this deal, said analysts….

Want to know more click here go to source.